Brief: Tempest Granted Fast Track Designation From The U.S. Food And Drug Administration For Amezalpat

Tempest Therapeutics

10/02/2025 13:04

Feb 10 (Reuters) - Tempest Therapeutics  TPST.O :
    * TEMPEST GRANTED FAST TRACK DESIGNATION FROM THE U.S. FOOD
AND
DRUG ADMINISTRATION FOR AMEZALPAT TO TREAT PATIENTS WITH
HEPATOCELLULAR CARCINOMA

Source text:  ID:nGNX5h7lh8 
Further company coverage:  TPST.O 

 ((Reuters.Briefs@thomsonreuters.com;))